436 related articles for article (PubMed ID: 32279542)
21. Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV.
Trunfio M; De Francesco D; Vai D; Medina C; Milesi M; Domini S; Alcantarini C; Imperiale D; Bonora S; Di Perri G; Calcagno A
AIDS Behav; 2022 Jul; 26(7):2203-2211. PubMed ID: 34982319
[TBL] [Abstract][Full Text] [Related]
22. Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study.
Kinai E; Komatsu K; Sakamoto M; Taniguchi T; Nakao A; Igari H; Takada K; Watanabe A; Takahashi-Nakazato A; Takano M; Kikuchi Y; Oka S;
J Neurovirol; 2017 Dec; 23(6):864-874. PubMed ID: 28971376
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders.
Tierney SM; Sheppard DP; Kordovski VM; Faytell MP; Avci G; Woods SP
J Neurovirol; 2017 Jun; 23(3):404-421. PubMed ID: 28108972
[TBL] [Abstract][Full Text] [Related]
24. Psycho-behavioral factors associated with neurocognitive performance among people living with HIV on antiretroviral therapy in Accra, Ghana.
Asiedu N; Kretchy I; Asampong E
Afr Health Sci; 2020 Jun; 20(2):487-596. PubMed ID: 33163015
[TBL] [Abstract][Full Text] [Related]
25. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
[TBL] [Abstract][Full Text] [Related]
26. Neurological soft signs as a marker of cognitive impairment severity in people living with HIV.
Toro P; Ceballos ME; Pesenti J; Inostroza M; Valenzuela D; Henríquez F; Forno G; Herold C; Schröder J; Calderón J
Psychiatry Res; 2018 Aug; 266():138-142. PubMed ID: 29870954
[TBL] [Abstract][Full Text] [Related]
27. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.
Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T
PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530
[TBL] [Abstract][Full Text] [Related]
28. Development of a neurocognitive test battery for HIV-associated neurocognitive disorder (HAND) screening: suggested solutions for resource-limited clinical settings.
Chan LG; Ho MJ; Lin YC; Ong Y; Wong CS
AIDS Res Ther; 2019 Apr; 16(1):9. PubMed ID: 30987670
[TBL] [Abstract][Full Text] [Related]
29. HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project.
Ku NS; Lee Y; Ahn JY; Song JE; Kim MH; Kim SB; Jeong SJ; Hong KW; Kim E; Han SH; Song JY; Cheong HJ; Song YG; Kim WJ; Kim JM; Smith DM; Choi JY
HIV Med; 2014 Sep; 15(8):470-7. PubMed ID: 24580888
[TBL] [Abstract][Full Text] [Related]
30. A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.
Vassallo M; Fabre R; Durant J; Lebrun-Frenay C; Joly H; Ticchioni M; DeSalvador F; Harvey-Langton A; Dunais B; Laffon M; Cottalorda J; Dellamonica P; Pradier C
J Neurovirol; 2017 Apr; 23(2):216-225. PubMed ID: 27815816
[TBL] [Abstract][Full Text] [Related]
31. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
[TBL] [Abstract][Full Text] [Related]
32. Improvement of HIV-associated neurocognitive disorders after antiretroviral therapy intensification: the Neuro+3 study.
Force G; Ghout I; Ropers J; Carcelain G; Marigot-Outtandy D; Hahn V; Darchy N; Defferriere H; Bouaziz-Amar E; Carlier R; Dorgham K; Callebert J; Peytavin G; Delaugerre C; de Truchis P;
J Antimicrob Chemother; 2021 Feb; 76(3):743-752. PubMed ID: 33179033
[TBL] [Abstract][Full Text] [Related]
33. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.
Joska JA; Witten J; Thomas KG; Robertson C; Casson-Crook M; Roosa H; Creighton J; Lyons J; McArthur J; Sacktor NC
AIDS Behav; 2016 Aug; 20(8):1621-31. PubMed ID: 26860536
[TBL] [Abstract][Full Text] [Related]
34. Screening HIV-associated neurocognitive disorders (HAND) among HIV positive patients attending antiretroviral therapy in South Wollo, Ethiopia.
Tsegaw M; Andargie G; Alem G; Tareke M
J Psychiatr Res; 2017 Feb; 85():37-41. PubMed ID: 27821271
[TBL] [Abstract][Full Text] [Related]
35. The Montreal Cognitive Assessment-Basic (MoCA-B) is not a reliable screening tool for cognitive decline in HIV patients receiving combination antiretroviral therapy in rural South Africa.
Hakkers CS; Beunders AJM; Ensing MHM; Barth RE; Boelema S; Devillé WLJ; Tempelman HA; Coutinho RA; Hoepelman AIM; Arends JE; van Zandvoort MJE
Int J Infect Dis; 2018 Feb; 67():36-40. PubMed ID: 29183843
[TBL] [Abstract][Full Text] [Related]
36. Routine detection and management of neurocognitive impairment in HIV-positive patients in a UK centre.
Haddow LJ; Accoroni A; Cartledge JD; Manji H; Benn P; Gilson RJ
Int J STD AIDS; 2013 Mar; 24(3):217-9. PubMed ID: 23535355
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and Risk Factors of HIV-Associated Neurocognitive Disorders in Rural Southwestern Uganda.
Namagga JK; Rukundo GZ; Voss JG
J Assoc Nurses AIDS Care; 2019; 30(5):531-538. PubMed ID: 31461736
[TBL] [Abstract][Full Text] [Related]
38. Empiric neurocognitive performance profile discovery and interpretation in HIV infection.
Gomez D; Power C; Gill MJ; Koenig N; Vega R; Fujiwara E
J Neurovirol; 2019 Feb; 25(1):72-84. PubMed ID: 30519968
[TBL] [Abstract][Full Text] [Related]
39. Use of Western Neuropsychological Test Battery in Detecting HIV-Associated Neurocognitive Disorders (HAND) in Zambia.
Kabuba N; Anitha Menon J; Franklin DR; Heaton RK; Hestad KA
AIDS Behav; 2017 Jun; 21(6):1717-1727. PubMed ID: 27278547
[TBL] [Abstract][Full Text] [Related]
40. Depression and diagnosis of neurocognitive impairment in HIV-positive patients.
Pinheiro CA; Souza LD; Motta JV; Kelbert EF; Souza MS; Martins CS; Coelho FM; Pinheiro KA; Pinheiro RT
Braz J Med Biol Res; 2016 Sep; 49(10):e5344. PubMed ID: 27626305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
